ALX ONCOLOGY HOLDINGS INC (ALXO) Form 8-K Material Events
ALX ONCOLOGY HOLDINGS INC (ALXO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALXO
CIK: 1810182
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerLindsay Brusco
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-16 | — | SCHEDULE 13D/A Filing | 0000905148-26-004485 | View SEC Doc Filr Page |
| 8-K | 2026-10-15 | 2026-10-14 | 8-K | 0001193125-26-422992 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355764 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355761 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352359 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-337920 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336843 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002155 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296246 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-29 | 8-K | 0001193125-26-290447 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-25 | 8-K | 0001193125-26-285425 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | 8-K | 0001193125-26-267472 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-27 | — | SCHEDULE 13D/A Filing | 0001643828-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062566 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062512 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001193125-26-213399 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | 8-K | 0001193125-26-213380 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-28 | — | SCHEDULE 13G/A Filing | 0001104659-26-050505 | View SEC Doc Filr Page |
| ARS | 2026-04-20 | 2025-12-31 | ARS | 0001193125-26-164310 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-20 | 2026-04-17 | DEF 14A | 0001193125-26-163936 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-16 | 4 | 0001193125-26-161558 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-16 | 4 | 0001193125-26-161557 | View SEC Doc Filr Page |
| 3 | 2026-04-17 | 2026-04-13 | 3 | 0001193125-26-161540 | View SEC Doc Filr Page |
| 8-K | 2026-04-13 | 2026-04-13 | 8-K | 0001193125-26-152050 | View SEC Doc Filr Page |
| 4 | 2026-03-23 | 2026-03-19 | 4 | 0001193125-26-119705 | View SEC Doc Filr Page |